The Denver-based company receives Medicare and Medicaid funding to provide healthcare to seniors at centers across several states. According to the Justice Department, InnovAge did not maintain adequate specialist provider networks and often failed to schedule appointments or consultations promptly in fields including oncology, cardiology, surgery and neurology. The department said those practices meant the company did not meet requirements of the dual Medicare-Medicaid program.
InnovAge said it had worked closely with the Centers for Medicare and Medicaid Services and state government partners, while investing to strengthen its clinical operations, compliance infrastructure and care delivery. A company spokesperson said the settlement resolves historical allegations without an admission of wrongdoing and allows InnovAge to continue focusing on care for the frail seniors it serves.
Under the agreement, about $25.7 million will go to the U.S. and a combined $10.3 million to Colorado, California, New Mexico and Virginia.




Comments (0)
No comments yet. Be the first!